Skip to main content
Figure 2 | BMC Health Services Research

Figure 2

From: Drug costs in the management of metastatic castration-resistant prostate cancer in Canada

Figure 2

Mean cumulative drugs cost per patient over the mCRPC treatment sequences, by type of medication; A) Current model and B) Alternate model. Abbreviations: 2nd HT = second line hormone therapy; 2nd HT wd = second line hormone therapy withdrawal; 1st chemo = first-line chemotherapy; 3rd HT = third line hormone therapy; 2nd chemo = second-line chemotherapy; OtherTx = Other treatments state; *assuming that only 95% of patients have received medication for medical castration; **assuming that only 90% of patients have received bone-targeted therapy.

Back to article page